Bradycardia associated with remdesivir therapy for COVID-19 in a 59-year-old man.

Day, Leora Branfield; Abdel-Qadir, Husam; Fralick, Michael

Day, Leora Branfield; Abdel-Qadir, Husam; Fralick, Michael.

Day LB; Division of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women's College Hospital, Toronto, Ont.
Abdel-Qadir H; Division of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women's College Hospital, Toronto, Ont.
Fralick M; Division of General Internal Medicine (Branfield Day, Fralick), Sinai Health System; Division of Cardiology (Abdel-Qadir), Women's College Hospital, Toronto, Ont. mike.fralick@mail.utoronto.ca.

CMAJ ; 193(17): E612-E615, 2021 04 26.

Article in English | MEDLINE | ID: covidwho-1207651

Subject(s)

Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; Antiviral Agents/adverse effects; Bradycardia/chemically induced; Bradycardia/diagnosis; COVID-19 Drug Treatment; Adenosine Monophosphate/adverse effects; Alanine/adverse effects; Humans; Male; Middle Aged

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Bradycardia / Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment Type of study: Case report / Diagnostic study Limits: Humans / Male / Middle aged Language: English Journal: CMAJ Journal subject: Medicine Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google